logo
episode-header-image
Apr 2024
19m 57s

T-Cell Malignant Neoplasms After Chimeri...

JAMA NETWORK
About this episode

Interview with Roni Shouval, MD, PhD, author of T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. Hosted by Vivek Subbiah, MD. Related Content:

Up next
Sep 18
Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer
Interview with Jiyoung Ahn, PhD, author of Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. Hosted by Vivek Subbiah, MD. Related Content: Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer 
13m 26s
Jul 31
Proportional Sedation for Persistent Agitated Delirium in Palliative Care
Interview with David Hui, MD, and Eduardo Bruera, MD, authors of Proportional Sedation for Persistent Agitated Delirium in Palliative Care: A Randomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Proportional Sedation for Persistent Agitated Delirium in Palliat ... Show More
17m 43s
May 2025
New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. Hosted by Vivek Subbiah, MD. Related Content: New Definition of Light Chain Monoclonal Gammopathy of Undetermined ... Show More
18m 54s
Recommended Episodes
Oct 2024
Baroreflex Sensitivity in Patients With Laryngopharyngeal Dysfunction
Interview with S. A. Reza Nouraei, BChir, PhD, author of Baroreflex Sensitivity in Patients With Laryngopharyngeal Dysfunction—The Overwhelmed Vagus Hypothesis. Hosted by Paul C. Bryson, MD, MBA. Related Content: Baroreflex Sensitivity in Patients With Laryngopharyngeal Dysfuncti ... Show More
13m 19s
Apr 2025
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma
Interview with Kevin J. Contrera, MD, MPH, author of Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neoadjuvant Therapy for Mucosal Head and Neck Squamous ... Show More
12m 19s
Jul 31
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab
Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA. Related Content: Pathologic Treatment Effect and Survival in HPV-Ne ... Show More
17m 45s
Dec 2023
A natural history of familial platelet disorder with myeloid malignancy; HEXIM1 as an essential transcription regulator in erythropoiesis; residual disease predicts relapse in CML patients
In this week's episode we’ll discuss the findings from a natural history study of patients with familial platelet disorder with myeloid malignancy, learn more about the role of HEXIM1 as an essential transcription regulator in human erythropoiesis, and discuss the utility of resi ... Show More
21m 53s
Sep 2023
Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction
Interview with Jay F. Piccirillo, MD, author of Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction 
14m 21s
Feb 2025
Manual Therapy for Fibrosis-Related Late Effect Dysphagia in HNC Survivors
Interview with Katherine A. Hutcheson, PhD, author of Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors: The MANTLE Nonrandomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Manual Therapy for Fibrosis-Related Late ... Show More
19m 35s
Aug 14
Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia
Interview with Nyssa Fox Farrell, MD, and Lara W. Crock, MD, PhD, MSCI, authors of Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia: A Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Stellate Ganglion Block for the Treatment of ... Show More
19m 42s
Nov 2023
S2 Episode 6: Rare Disease: Is It Membranous Nephropathy?
Join experts Drs Matthew Sparks and Laurence Beck as they discuss the diagnosis and management of membranous nephropathy, a rare kidney disease. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991606). The topics and ... Show More
29m 23s
Nov 2024
CAR T Cells and T-Cell Therapies for Cancer
CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, M ... Show More
18m 22s
Aug 2024
Iron, HFE haemochromatosis, and infections; bispecific antibodies improve CAR T-cell response; determinants of outcome in NPM1-mutated AML
In this week's episode we'll learn about iron, HFE hemochromatosis, and infections. In this large, population-based study, both high and low levels of plasma iron and transferrin saturation were associated with increased risks of infection. Then, we'll discuss how bispecific anti ... Show More
23m 31s